The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
| Angus Thompson, Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs
Presenteeism, reduced productivity while working, has come into consideration as a major occupational health problem in many countries with serious consequences for both organizations and employees. Increasing evidence shows that presenteeism represents a significant source of productivity losses that can cost organizations much more than does absenteeism, and it can lead to an…
This report is from an Alberta Strategic Clinical Networks (SCN) exchange meeting with Mr. Neil Fraser. This event brought together SCNs and related health system stakeholders, and a leader in the Canadian medical technology industry, and recent member of a Federal Advisory Panel on Healthcare Innovation. The meeting had the objectives to help the SCNs to understand the Advisory…
Background: Significant gaps in the evidence base on costs in rural communities in Canada and elsewhere are reported in the literature, particularly regarding costs to families. However, it remains unclear whether the costs related to all resources used by palliative care patients in rural areas differ to those resources used in urban areas.
PDF of a PowerPoint presentation by Dr. Stan Kutcher, ONS, MD, FRCPC, FCAHS, Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University and IWK Health Centre.
IHE Innovation Forum XIV – Strengthening Mental Health Services for Children and Families
The Institute of Health Economics held a roundtable on June 4, 2015, entitled Innovative Funding Models: Kidney Care Policy Options for the Future, to identify and discuss key issues in kidney care policy options. Prior to the roundtable, an Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference refined project objectives, and the…
PDF of a PowerPoint presentation by Dr. Irvin Mayers, Professor, Division of Pulmonary Medicine, University of Alberta; Chair of the COPD Policy Framework Study Expert Advisory Committee.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Arianna Waye, Health Economist, Institute of Health Economics.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Michael G. Stewart, Director, Clinical Support Branch, Ontario Ministry of Health and Long-Term Care.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Michael Stickland, Associate Professor, Division of Pulmonary Medicine, University of Alberta; Heart & Stroke Foundation New Investigator.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Simon Lessard, Quebec Lung Association Board & Scientific Committee Member, Community Pharmacist.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Cathy Clelland, Head of Department of Family Practice, Royal Columbian Hospital; Consultant, General Practitioners Services Committee, British Columbia.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Stephen Samis, Vice President, Programs, Canadian Foundation for Healthcare Improvement; and Dr. Graeme Rocker, Professor of Medicine, Dalhousie University; Faculty, Canadian Foundation for Healthcare Improvement.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
The Institute of Health Economics (IHE), in partnership with Boehringer Ingelheim (Canada) Ltd./Ltée held an invitational forum on October 3, 2015, in Edmonton, Alberta. The purpose of this discussion was to bring together multiple stakeholders from across Canada to investigate the current state of evidence and information regarding idiopathic pulmonary fibrosis (IPF) and…
Objective: In this study, we estimate the impact of the new PCV13 immunization program on the burden of disease and related healthcare costs in Alberta.
OBJECTIVES: To examine differences in health services utilization (HSU) costs in the first year of life between low birth weight (LBW) and normal birth weight (NBW) infants, identify maternal and child characteristics associated with HSU costs, and estimate annual HSU cost of LBW infants for the province of Alberta, Canada.
| Bing Guo, Carmen Moga, Christa Harstall, Don Schopflocher
Objective: Because of a lack of a control group, a case-series study is considered one of the weaker study designs from which to obtain evidence on treatment effectiveness. Under certain circumstances, however, this is the only available evidence to inform health-care decisions. This study's intent was to develop and validate a quality appraisal checklist specifically for…
| Werner J Becker, Ted Findlay, Carmen Moga, Ann Scott, Christa Harstall, Paul Taenzer
Objective: To increase the use of evidence-informed approaches to diagnosis, investigation, and treatment of headache for patients in primary care.
Note: This is an Alberta Ambassador Guideline Adaptation Program related publication.
Alberta Health Services (AHS) has recently established a number of Strategic Clinical Networks (SCNs) in the province around specific health care topics (e.g., Cardiovascular Health & Stroke) and within areas where care is delivered (e.g., Surgery). The SCNs are the engines of innovation in the health system and have a mandate to find new and innovative ways of delivering care…
| Don Husereau, Larry Arshoff, Shahira Bhimani, Nicola Allen
This document describes the entry of new medical devices into the Canadian health system. It is intended to provide an accurate description of new medical device entry in Canada, and is intended to give patients, the public, private and public sector health system researchers, medical device companies, and private and public coverage bodies a general understanding of what regulatory,…
Written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an assessment of how the adoption of fFN testing in Alberta impacted the clinical management of preterm labour and healty system resources. This was also an opportunity to retroactively use the Post Policy Implementation Framework to evaluate a specific policy developed within…
PDF of a PowerPoint presentation by Mr. Neil Fraser, President & GM, Medtronic Canada, Incoming Chair of MEDEC.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Dr. Blair O'Neill, Associate Chief Medical Officer, SCNs.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Mr. Jitendra Prasad, Chief Program Officer, Contracting, Procurement & Supply Management, AHS.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
We reviewed literature to estimate the costs of Fetal Alcohol Spectrum Disorder (FASD) in the Canadian Criminal Justice System (CJS), and to update the total costs of FASD in Canada. The results suggest FASD is costlier than previous estimates. The costs of FASD associated with the CJS are estimated at $3.9 billion a year, with $1.2 billion for police, $0.4 billion for court,…
| Julie Polisena, John Lavis, Don Juzwishin, Pam McLean-Veysey, Ian Graham, Christa Harstall, Janet Martin
A perceived gap exists in how well Canadian health technology assessment (HTA) producers are supporting the use of their HTAs by decision-makers. The authors propose that the newly released HTA Database Canadian search interface incorporate structured decision-relevant summaries of HTAs that would be developed by participating Canadian HTA organizations. The registry would…
| Ann Scott, Dion Pasichnyk, Christa Harstall, Dagmara Chojecki
This Information Paper is an inventory and broad summary of factors affecting the adoption and diffusion of health technologies and of available models, strategies, tools, and processes for optimizing health technology diffusion.
| Braden Manns, Anderson Chuck, Eddy Nason, Lianne Barnieh, John Sproule, Jasmine Brown
This work, conducted by the Institute for Health Economics (IHE) and the University of Calgary (Health Economics group), was performed to better understand the unmet educational needs and health economics products that could support people in the province, and to determine the current capacity for conducting health economics in Alberta. This paper seeks to understand the needs…
PDF of a PowerPoint presentation by Dr. Andrew Bjerring, Council of Canadian Academies.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
PDF of a PowerPoint presentation by Mr. William Falk, Rotman School of Management, University of Toronto.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
Objectives: Economic evaluations, although not formally used in purchasing decisions for medical devices in Canada, are still being conducted and published. The aim of this study was to examine the way that prices have been included in Canadian economic evaluations of medical devices.
Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices by bringing together economists and other…
| Deborah Marshall, Egon Jonsson, Liam Martin, Diane Mosher, Karen V. MacDonald
This White Paper discusses the concept of developing a comprehensive rheumatoid arthritis registry in Alberta, and the important health, social, and economic gains such a resource would generate for Alberta.
The Federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
This book includes the plenary presentations made at the first international conference on prevention of FASD, which was attended by about 700 people from 35 countries around the globe. The issues addressed are FASD as a priority in health policy making; its prevalence and incidence; strategies for prevention; current applied and basic research in the field; the role of the medical…
Fetal alcohol spectrum disorder (FASD) is of growing concern around the world. A range of disabilities caused by prenatal exposure to alcohol, FASD is estimated to affect 2% to 5% of all newborns in the industrialized countries of Europe and North America, and the rates may be significantly higher in some developing countries and certain defined populations. Epidemiological studies…
| Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs, Angus Thompson
Objectives: To assess and compare the measurement properties (ie, validity, reliability, responsiveness) and the quality of the evidence of presenteeism instruments.
| Thanh Nguyen, Egon Jonsson, Jessica Moffatt, Liz Dennett, Anderson Chuck, Shelley Birchard
Abstract: Parent-Child Assistance Program (P-CAP) is a 3-year home visitation/harm reduction intervention to prevent alcohol exposed births, thereby births with fetal alcohol spectrum disorder, among high-risk women. This article used a decision analytic modelling technique to estimate the incremental cost-effectiveness ratio and the net monetary benefit of the P-CAP…
PDF of a PowerPoint Presentation by Dr. Siok Swan Tan, Erasmus University, institute for Medical Technology Assessment (iMTA).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mrs. Lesley Curtis, Personal Social Services Research Unit (PSSRU), UK.
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Dr. Unto Häkkinen, National Institute for Health and Welfare (THL).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Ms. Karen Lee, Canadian Agency for Drugs and Technologies in Health (CADTH).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Michael Stewart, Ontario Ministry of Health and Long-Term Care (MOHLTC).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Anyk Glussich, Program Lead, Canadian Patient Cost Database (CPCD); Canadian Institute for Health Information (CIHI).
On the State of the Art in Costing Methods Workshop.
| Lindsay Wodinski, Kate Woodman, Margaret Wanke, Thanh Nguyen, Philip Jacobs
Abstract: Alberta's Primary Care Networks (PCNs) bring together family physicians and other health professionals to provide local, comprehensive, and readily accessible primary care services to patients. The Edmonton North PCN, one of the largest in the province, piloted the Resource in Clinic (RIC) Program with objectives to increase efficiencies in the use of physician…
| Sue Ludwig, Patricia Leggett Tait, Christa Harstall
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #22. This review was requested to determine whether conductive education as a learning approach or therapeutic intervention is safe and efficacious for children with disabilities such as cerebral palsy that impact neuromotor functioning. The review also addresses the profile of the child who would benefit from…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #18. This report has been prepared following interest by the Alberta Cord Blood Bank in obtaining advice on the comparative effectiveness and costs of different types of stem cell transplantation. Earlier assessments by the Foundation have considered peripheral blood stem cell transplantation and cord blood transplantation.…